Skip to main navigation
Skip to search
Skip to main content
Icahn School of Medicine at Mount Sinai Home
Help & FAQ
Home
Profiles
Research units
Publications & Research Outputs
Press/Media
Search by expertise, name or affiliation
Rational development of addiction pharmacotherapies: Successes, failures, and prospects
R. Christopher Pierce
, Charles P. O'Brien
,
Paul J. Kenny
, Louk J.M.J. Vanderschuren
Research output
:
Contribution to journal
›
Review article
›
peer-review
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Rational development of addiction pharmacotherapies: Successes, failures, and prospects'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Addiction
100%
Cocaine Dependence
100%
Pharmacotherapy
100%
Success Failure
100%
Animal Research
100%
Rational Development
100%
Psychostimulant Addiction
66%
Alcohol Addiction
66%
Opioid Addiction
66%
Nicotine Dependence
66%
Animal Models of Addiction
66%
Drug Therapy
33%
Predictive Validity
33%
Antidepressants
33%
U.S. Food
33%
Addiction Models
33%
Rationally Designed
33%
Pharmacological Mechanism
33%
Pharmaceutics
33%
Analgesic
33%
Dopamine Receptor Antagonist
33%
D1 Dopamine Receptor
33%
Ecopipam
33%
Effective Compounds
33%
Pharmacology, Toxicology and Pharmaceutical Science
Pharmacotherapy
100%
Cocaine Dependence
100%
Tobacco Dependence
66%
Psychostimulant
66%
Opiate Addiction
66%
Antidepressant
33%
Analgesic Agent
33%
Ecopipam
33%
Dopamine 1 Receptor Blocking Agent
33%
Neuroscience
Cocaine Dependence
100%
Drug Therapy
100%
Psychostimulant
66%
Opioid Dependence
66%
Tobacco Dependence
66%
Antidepressant
33%
Dopamine Receptor D1
33%
Dopamine Antagonist
33%